1 Weissman MM, Leaf PJ, Tischler GL, et al. Affective disorders in five United States communities. Psychol Med. 1988; 18(1):141-153. doi:10.1017/S0033291700001975.
2 Mitchell PB, Slade T, Andrews G. Twelve-month prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey. Psychol Med. 2004; 34(5):777-785. doi:10.1017/S0033291703001636.
3 Grant BF, Stinson FS, Hasin DS, et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005; 66(10):1205-1215. doi:10.4088/JCP.v66n1001.
4 Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch Gen Psychiatry. 2007; 64(5):543-552. doi:10.1001/archpsyc.64.5.543.
5 Bijl R V., de Graaf R, Ravelli A, Smit F, Vollebergh WAM. Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population. Results from the Netherlands mental health survey and incidence study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 2002; 37(8):372-379. doi:10.1007/s00127-002-0566-3.
6 Kessler RC. Epidemiology of women and depression. In: Journal of Affective Disorders. Vol 74. Elsevier; 2003:5-13. doi:10.1016/S0165-0327(02)00426-3.
7 Leach LS, Christensen H, Mackinnon AJ, Windsor TD, Butterworth P. Gender differences in depression and anxiety across the adult lifespan: The role of psychosocial mediators. Soc Psychiatry Psychiatr Epidemiol. 2008; 43(12):983-998. doi:10.1007/s00127-008-0388-z.
8 Kennedy N, Boydell J, Kalidindi S, et al. Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry. 2005; 162(2):257-262. doi:10.1176/appi.ajp.162.2.257.
9 Kessing LV. Gender differences in the phenomenology of bipolar disorder. Bipolar Disord. 2004; 6(5):421-425. doi:10.1111/j.1399-5618.2004.00135.x.
10 Nivoli AMA, Pacchiarotti I, Rosa AR, et al. Gender differences in a cohort study of 604 bipolar patients: The role of predominant polarity. J Affect Disord. 2011; 133(3):443-449. doi:10.1016/j.jad.2011.04.055.
11 Baldassano CF, Marangell LB, Gyulai L, et al. Gender differences in bipolar disorder: Retrospective data from the first 500 STEP-BD participants. Bipolar Disord. 2005; 7(5):465-470. doi:10.1111/j.1399-5618.2005.00237.x.
12 Slyepchenko A, Frey BN, Lafer B, Nierenberg AA, Sachs GS, Dias RS. Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study. Acta Psychiatr Scand. 2017; 136(5):473-482. doi:10.1111/acps.12797.
13 Tondo L, Baldessarini RJ. Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry. 1998; 155(10):1434-1436. doi:10.1176/ajp.155.10.1434.
14 Diflorio A, Jones I. Is sex important Gender differences in bipolar disorder. Int Rev Psychiatry. 2010; 22(5):437-452. doi:10.3109/09540261.2010.514601
15 Arnold LM, McElroy SL, Keck PE. The role of gender in mixed mania. Compr Psychiatry. 2000; 41(2):83-87. doi:10.1016/S0010-440X(00)90137-8.
16 Clements C, Morriss R, Jones S, Peters S, Roberts C, Kapur N. Suicide in bipolar disorder in a national English sample, 1996-2009: Frequency, trends and characteristics. Psychol Med. 2013; 43(12):2593-2602. doi:10.1017/S0033291713000329.
17 Hendrick V, Altshuler LL, Gitlin MJ, Delrahim S, Hammen C. Gender and bipolar illness. J Clin Psychiatry. 2000; 61(5):393-396. doi:10.4088/JCP.v61n0514.
18 Suppes T, Mintz J, McElroy SL, et al. Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: A sex-specific phenomenon. Arch Gen Psychiatry. 2005; 62(10):1089-1096. doi:10.1001/archpsyc.62.10.1089.
19 Altshuler LL, Kupka RW, Hellemann G, et al. Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Outcome Network. Am J Psychiatry. 2010; 167(6):708-715. doi:10.1176/appi.ajp.2009.09010105.
20 Clemente AS, Diniz BS, Nicolato R, et al. Bipolar disorder prevalence: A systematic review and meta-analysis of the literature. Rev Bras Psiquiatr. 2015; 37(2):155-161. doi:10.1590/1516-4446-2012-1693.
21 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edi. Arlington, VA: American Psychiatric Publishing, Inc.; 1994.
22 Culpepper L. Misdiagnosis of bipolar depression in primary care practices. J Clin Psychiatry. 2014; 75(3). doi:10.4088/JCP.13019tx1c.
23 Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RMA. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994; 31(4):281-294. doi:10.1016/0165-0327(94)90104-X.
24 Hirschfeld RMA, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: How far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 Survey of individuals with bipolar disorder. J Clin Psychiatry. 2003; 64(2):161-174. doi:10.4088/JCP.v64n0209.
25 Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry. 1987; 144(11):1403-1411. doi:10.1176/ajp.144.11.1403.
26 Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: A Swedish national cohort study. JAMA Psychiatry. 2013; 70(9):931-939. doi:10.1001/jamapsychiatry.2013.1394.
27 Karanti A, Bobeck C, Osterman M, et al. Gender differences in the treatment of patients with bipolar disorder: A study of 7354 patients. J Affect Disord. 2015; 174:303-309. doi:10.1016/j.jad.2014.11.058.
28 Hayes JF, Marston L, Walters K, King MB, Osborn DPJ. Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014. Br J Psychiatry. 2017; 211(3):175-181. doi:10.1192/bjp.bp.117.202606.
29 Kim L, Kim J-A, Kim S. A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples. Epidemiol Health. 2014; 36. doi:10.4178/EPIH/E2014008.
30 Yoon W, Shon SH, Hong Y, Joo YH, Lee JS. Antidepressant prescription patterns in bipolar disorder: A nationwide, register-based study in Korea. J Korean Med Sci. 2018; 33(46). doi:10.3346/jkms.2018.33.e290.
31 Bareis N, Lu J, Kirkwood CK, Kornstein SG, Wu E, Mezuk B. Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Affect Disord. 2018; 238:147-155. doi:10.1016/j.jad.2018.05.063.
32 Bobo W V., Na PJ, Geske JR, McElroy SL, Frye MA, Biernacka JM. The relative influence of individual risk factors for attempted suicide in patients with bipolar I versus bipolar II disorder. J Affect Disord. 2018; 225:489-494. doi:10.1016/j.jad.2017.08.076.
33 Buoli M, Cesana BM, Maina G, et al. Correlates of current rapid-cycling bipolar disorder: Results from the Italian multicentric RENDiBi study. Eur Psychiatry. 2019; 62:82-89 doi:10.1016/j.eurpsy.2019.09.001.
34 Vieta E, Langosch JM, Figueira ML, et al. Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd). Int J Neuropsychopharmacol. 2013; 16(8):1719-1732. doi:10.1017/S1461145713000278.
35 Hou L, Heilbronner U, Degenhardt F, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: A genome-wide association study. Lancet. 2016; 387(10023):1085-1093. doi:10.1016/S0140-6736(16)00143-4.
36 Kalman JL, Papiol S, Forstner AJ, et al. Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study. Bipolar Disord. 2019; 21(1):68-75. doi:10.1111/bdi.12659.
37 Ferrari AJ, Stockings E, Khoo JP, et al. The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013. Bipolar Disord. 2016;18(5):440-450. doi:10.1111/bdi.12423
38 Carvalho AF, Dimellis D, Gonda X, Vieta E, McIntyre RS, Fountoulakis KN. Rapid cycling in bipolar disorder: A systematic review. J Clin Psychiatry. 2014; 75(6). doi:10.4088/JCP.13r08905.
39 Morgan VA, Mitchell PB, Jablensky A V. The epidemiology of bipolar disorder: Sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders. Bipolar Disord. 2005; 7(4):326-337. doi:10.1111/j.1399-5618.2005.00229.x.
40 Valentí M, Pacchiarotti I, Undurraga J, et al. Risk factors for rapid cycling in bipolar disorder. Bipolar Disord. 2015; 17(5):549-559. doi:10.1111/bdi.12288.
41 Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: A systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161(9):1537-1547. doi:10.1176/appi.ajp.161.9.1537
42 Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression. N Engl J Med. 2007;356(17):1711-1722. doi:10.1056/NEJMoa064135
43 Price LH, Tyrka AR. Adjunctive antidepressant treatment for bipolar depression [1]. N Engl J Med. 2007;357(6):614-616. doi:10.1056/NEJMc071459
44 Bodén R, Lundgren M, Brandt L, Reutfors J, Andersen M, Kieler H. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: Population based cohort study. BMJ. 2012; 345(7883). doi:10.1136/bmj.e7085.
45 Wesseloo R, Kamperman AM, Munk-Olsen T, Pop VJM, Kushner SA, Bergink V. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: A systematic review and meta-analysis. Am J Psychiatry. 2016; 173(2):117-127. doi:10.1176/appi.ajp.2015.15010124.
46 Viguera AC, Tondo L, Koukopoulos AE, Reginaldi D, Lepri B, Baldessarini RJ. Episdes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry. 2011; 168(11):1179-1185. doi:10.1176/appi.ajp.2011.11010148.
47 Studd J, Panay N. Are oestrogens useful for the treatment of depression in women? Best Pract Res Clin Obstet Gynaecol. 2009; 23(1):63-71. doi:10.1016/j.bpobgyn.2008.11.001.
48 Joffe RT. Hormone treatment of depression. Dialogues Clin Neurosci. 2011; 13(1):127-138.
49 Graziottin A, Serafini A. Depression and the menopause: Why antidepressants are not enough? Menopause Int. 2009; 15(2):76-81. doi:10.1258/mi.2009.009021.
50 Robakis TK, Holtzman J, Stemmle PG, Reynolds-May MF, Kenna HA, Rasgon NL. Lamotrigine and GABAA receptor modulators interact with menstrual cycle phase and oral contraceptives to regulate mood in women with bipolar disorder. J Affect Disord. 2015; 175:108-115. doi:10.1016/j.jad.2014.12.040.
51 Michl LC, McLaughlin KA, Shepherd K, Nolen-Hoeksema S. Rumination as a mechanism linking stressful life events to symptoms of depression and anxiety: Longitudinal evidence in early adolescents and adults. J Abnorm Psychol. 2013;122(2):339-352. doi:10.1037/a0031994
52 McLaughlin KA, Nolen-Hoeksema S. Rumination as a transdiagnostic factor in depression and anxiety. Behav Res Ther. 2011;49(3):186-193. doi:10.1016/j.brat.2010.12.006